|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.27 AUD | -1.72% |
|
+0.20% | -17.58% |
| 07-01 | Clinuvel Pharmaceuticals Extends CEO Philippe Wolgen's Term of Employment | MT |
| 06-15 | Clinuvel Pharmaceuticals Advances US Listing Plan With SEC Filing for Nasdaq ADS Upgrade | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Biopharmaceuticals | -1.72% | +0.20% | -17.58% | -1.91% | -61.98% | 366M |  |  | |
- Stock Market
- Stocks
- CUV Stock
- Charts Clinuvel Pharmaceuticals Limited
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
